Christopher Bull Granger, MD

Professor of Medicine
Professor in the School of Nursing
Member in the Duke Clinical Research Institute
Campus mail 2400 Pratt Street, Durham, NC 27705
Phone (919) 668-8900
Email address grang001@mc.duke.edu

Research:
My primary research interest is in conduct and methodology of large randomized clinical trials in heart disease. I have led a number of large international clinical studies in heart attacks, unstable angina, heart failure, and atrial fibrillation. I have lead clinical studies of blood thinners and coronary intervention for heart attacks, stroke prevention in atrial fibrillation, and prevention of heart attack for patients with coronary artery disease. I have been co-director of the Reperfusion of Acute MI in Carolina Emergency Departments (RACE) project that is a North Carolina state-wide program to improve reperfusion care for acute myocardial infarction. I serve as the Chairman of the American Heart Association Mission: Lifeline program to improve heart attack care nationally as well as the American College of Cardiology/American Heart Association guideline committee for heart attack care. I have also studied the effects of genetic variation on heart disease. I work with the National Institute of Health and the Federal Drug Administration on evaluation of heart disease and of new drugs. I have developed tools to predict which patients are at risk for death, heart attack, and need for hospitalization.

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1988 - 1990
  • Chief Medical Resident, Medicine, University of Colorado at Denver, 1987 - 1988
  • Medical Resident, Medicine, University of Colorado at Denver, 1984 - 1987
  • M.D., University of Connecticut, 1984

Publications

Lopes, RD, Vora, AN, Liaw, D, Granger, CB, Darius, H, Goodman, SG, Mehran, R, Windecker, S, and Alexander, JH. "An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial (Accepted)." American Heart Journal 200 (June 1, 2018): 17-23.

Full Text

Berwanger, O, de Barros e Silva, PGM, Dall Orto, FTC, de Andrade, PB, de Castro Bienert, IR, Bosso, CE, Mangione, J, Polanczyk, CA, Sousa, A, Kalil, R, de Moura Santos, L, Sposito, AC, Rech, RL, Sousa, ACS, Baldissera, F, Nascimento, BR, de Andrade Jesuíno, I, Santucci, EV, Damiani, LP, Laranjeira, LN, Borges de Oliveira, JA, Giraldez, RR, Cavalcanti, AB, Pereira, SB, Mattos, LA, Armaganijan, LV, Guimarães, HP, Sousa, JE, Alexander, JH, Granger, CB, and Lopes, RD. "Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE-PCI Trial." American Heart Journal 198 (April 1, 2018): 129-134.

Full Text

Goto, S, Merrill, P, Wallentin, L, Wojdyla, DM, Hanna, M, Avezum, A, Easton, JD, Harjola, V-P, Huber, K, Lewis, BS, Parkhomenko, A, Zhu, J, Granger, CB, Lopes, RD, and Alexander, JH. "Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE." European heart journal. Cardiovascular pharmacotherapy 4, no. 2 (April 2018): 75-81.

PMID
29385429
Full Text

Berwanger, O, Santucci, EV, de Barros E Silva, PGM, Jesuíno, IDA, Damiani, LP, Barbosa, LM, Santos, RHN, Laranjeira, LN, Egydio, FDM, Borges de Oliveira, JA, Dall Orto, FTC, Beraldo de Andrade, P, Bienert, IRDC, Bosso, CE, Mangione, JA, Polanczyk, CA, Sousa, AGDMR, Kalil, RAK, Santos, LDM, Sposito, AC, Rech, RL, Sousa, ACS, Baldissera, F, Nascimento, BR, Giraldez, RRCV, Cavalcanti, AB, Pereira, SB, Mattos, LA, Armaganijan, LV, Guimarães, HP, Sousa, JEMR, Alexander, JH, Granger, CB, and Lopes, RD et al. "Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial." JAMA 319, no. 13 (April 2018): 1331-1340.

PMID
29525821
Full Text

Writing Committee for the TREAT Study Group, , Berwanger, O, Nicolau, JC, Carvalho, AC, Jiang, L, Goodman, SG, Nicholls, SJ, Parkhomenko, A, Averkov, O, Tajer, C, Malaga, G, Saraiva, JFK, Fonseca, FA, De Luca, FA, Guimaraes, HP, de Barros E Silva, PGM, Damiani, LP, Paisani, DM, Lasagno, CMR, Candido, CT, Valeis, N, Moia, DDF, Piegas, LS, Granger, CB, White, HD, and Lopes, RD. "Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial." JAMA cardiology (March 11, 2018).

PMID
29525822
Full Text

Rao, MP, Vinereanu, D, Wojdyla, DM, Alexander, JH, Atar, D, Hylek, EM, Hanna, M, Wallentin, L, Lopes, RD, Gersh, BJ, Granger, CB, and Apixaban for Reduction in Stroke Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators, . "Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial." The American journal of medicine 131, no. 3 (March 2018): 269-275.e2.

PMID
29122636
Full Text

Wolsk, E, Claggett, B, Køber, L, Pocock, S, Yusuf, S, Swedberg, K, McMurray, JJV, Granger, CB, Pfeffer, MA, and Solomon, SD. "Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure." European journal of heart failure 20, no. 3 (March 2018): 504-510.

PMID
29193462
Full Text

Kopin, D, Jones, WS, Sherwood, MW, Wojdyla, DM, Wallentin, L, Lewis, BS, Verheugt, FWA, Vinereanu, D, Bahit, MC, Halvorsen, S, Huber, K, Parkhomenko, A, Granger, CB, Lopes, RD, and Alexander, JH. "Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial." American heart journal 197 (March 2018): 133-141.

PMID
29447773
Full Text

Lopes, RD, Rordorf, R, De Ferrari, GM, Leonardi, S, Thomas, L, Wojdyla, DM, Ridefelt, P, Lawrence, JH, De Caterina, R, Vinereanu, D, Hanna, M, Flaker, G, Al-Khatib, SM, Hohnloser, SH, Alexander, JH, Granger, CB, Wallentin, L, and ARISTOTLE Committees and Investigators, . "Digoxin and Mortality in Patients With Atrial Fibrillation." Journal of the American College of Cardiology 71, no. 10 (March 2018): 1063-1074.

PMID
29519345
Full Text

Bahit, MC, Kochar, A, and Granger, CB. "Post-Myocardial Infarction Heart Failure." JACC. Heart failure 6, no. 3 (March 2018): 179-186. (Review)

PMID
29496021
Full Text

Pages